不可逆电穿孔消融治疗胰腺癌的现状与展望

doi:10.3877/cma.j.issn.2095-5782.2017.03.017

不可逆电穿孔消融（纳米刀）作为一项新兴的介入消融技术，不同于传统的物理消融技术如射频消融、微波消融及冷冻消融等。不可逆电穿孔技术利用高电压脉冲使细胞膜出现纳米级微孔，细胞内环境失衡，最终导致细胞凋亡，但却对细胞外基质影响较小，所以此技术可以应用于邻近重要血管或神经的肿瘤消融。胰腺癌是消化道恶性程度最高的肿瘤之一，预后差且较难早期诊断，往往发现时已经是Ⅲ期或者Ⅳ期。近几年来，不可逆电穿孔消融凭借并发症少、安全性高等优点，逐步应用于不可切除胰腺癌的治疗。本文就不可逆电穿孔消融的基础研究、治疗胰腺癌的临床研究等问题作一综述。

关键词: 不可逆电穿孔, 胰腺癌, 消融, 钠米刀

As an emerging interventional ablation modality which is different from conventional physical ablation such as radiofrequency ablation, microwave ablation and cryoablation, irreversible electroporation(IRE) ablationutilizes high voltage pulses to create permanent nanopores in the cell membrane, which in turn induces apoptosis of targeted cells. The promising technology can be used to ablate tumors adjacent to vital structures due to its less impact on extracellular matrix. Pancreatic cancer, despite extensive research, remains the most aggressive gastrointestinal tumors, having a poor prognosis and ambiguous early symptom usually diagnosed at stage Ⅲ or Ⅳ. Recently, IRE ablation has being progressively applied in the management of unresectable pancreatic cancer by virtue of its high efficiency and safety. This article will review on the basic research of IRE, clinical application in pancreatic cancer and some indefinite questions.

Key words: Irreversible electroporation, Pancreatic Cancer, Ablation, Nanoknife

表1 纳米刀消融治疗胰腺癌的安全性和有效性研究

作者	例数	肿瘤最大径（cm）	术式	中位生存时间（月）	中位无进展生存时间（月）	局部复发率（%）	严重并发症比例*（%）
Scheffer等^[19]	25	4	CT引导经皮消融	17	8	-	47.80
Mansson等^[21]	24	4.5	超声引导经皮消融	17.9	6.1	58.30	25
Yan等^[22]	25	4.2	开放式消融	-	-	-	20
Martin等^[25]	200	2.8	原位消融（150）/边缘消融+切除（50）	23.2/28.3	12.4	29	32/30.6
Narayanan等^[26]	50	4.5	CT引导经皮消融	27	-	-	20
Kluger等^[27]	50	2.7/3.2	原位消融（29）/边缘消融+切除（21）	12.01	-	58	55.20
Belfiore等^[28]	29	-	CT引导经皮消融	14	-	-	-

表1 纳米刀消融治疗胰腺癌的安全性和有效性研究

作者	例数	肿瘤最大径（cm）	术式	中位生存时间（月）	中位无进展生存时间（月）	局部复发率（%）	严重并发症比例*（%）
Scheffer等^[19]	25	4	CT引导经皮消融	17	8	-	47.80
Mansson等^[21]	24	4.5	超声引导经皮消融	17.9	6.1	58.30	25
Yan等^[22]	25	4.2	开放式消融	-	-	-	20
Martin等^[25]	200	2.8	原位消融（150）/边缘消融+切除（50）	23.2/28.3	12.4	29	32/30.6
Narayanan等^[26]	50	4.5	CT引导经皮消融	27	-	-	20
Kluger等^[27]	50	2.7/3.2	原位消融（29）/边缘消融+切除（21）	12.01	-	58	55.20
Belfiore等^[28]	29	-	CT引导经皮消融	14	-	-	-

1	Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017[J]. CA Cancer J Clin，2017，67(1):7-30.
2	Gluth A, Werner J, Hartwig W. Surgical resection strategies for locally　advanced pancreatic cancer[J]. Langenbecks Arch Surg, 2015, 400(7):757-765.
3	中国癌症研究基金会介入医学委员会.晚期胰腺癌介入治疗临床操作指南(试行)[J].临床肝胆病杂志,2017,33(2):221-232.
4	Spadi R, Brusa F, Ponzetti A, et al. Current therapeutic strategies for advanced pancreatic cancer: A review for clinicians[J]. World J ClinOncol,2016,7(1):27-43.
5	Lu DS, Raman SS, Vodopich DJ, et al. Effect of vesselsize on creation of hepatic radiofrequency lesions in pigs: assessment of the "heat sink" effect[J]. AJR Am J Roentgenol, 2002, 178(1):47-51.
6	Gehl J. Electroporation: theory and methods, perspectives for drug delivery,gene therapy and research[J]. Acta Physiol Scand, 2003, 177(4):437-47.
7	Chang DC, Reese TS. Changes in membrane structure induced by electroporationas revealed by rapid-freezing electron microscopy[J]. Biophys J, 1990,58(1):1-12.
8	Joshi RP, Schoenbach KH. Bioelectric effects of intense ultrashort pulses[J]. Crit Rev Biomed Eng,2010,38(3):255-304.
9	Lee EW, Wong D, Prikhodko SV, et al. Electronmicroscopic demonstration and evaluation of irreversible electroporation-induced nanopores on hepatocyte membranes[J]. J Vasc Interv Radiol, 2012, 23(1):107-113.
10	Zhang Z, Li W, Procissi D, et al. Rapid dramaticalterations to the tumor microstructure in pancreatic cancer following　irreversible electroporation ablation[J]. Nanomedicine (Lond), 2014, 9(8):1181-1192.
11	Petrishia A, Sasikala M. Molecular simulation of cell membrane deformation by picosecond intense electric pulse[J]. J Membr Biol, 2015,248(6):1015-1020.
12	Paiella S, Salvia R, Ramera M, et al. Local ablative strategies for ductal pancreatic cancer (radiofrequency ablation, irreversible electroporation): A review[J]. Gastroenterol Res Pract, 2016, 2016:4508376.
13	Vogel JA, van Veldhuisen E, Agnass P, et al. Time-dependent impact of irreversible electroporation on pancreas, liver, blood vessels and nerves: a systematic review of experimental studies[J]. PLoS One, 2016,11(11):e0166987.
14	Bower M, Sherwood L, Li Y, et al. Irreversible electroporation of thepancreas: definitive local therapy without systemic effects[J]. J Surg Oncol, 2011,104(1):22-28.
15	José A, Sobrevals L, Ivorra A, et al. Irreversible electroporation shows　efficacy against pancreatic carcinoma without systemic toxicity in mouse models[J]. Cancer Lett, 2012, 317(1):16-23.
16	Fritz S, Sommer CM, Vollherbst D, et al. Irreversible electroporation of the pancreas isfeasible and safe in a porcine survival model[J]. Pancreas, 2015 ,44(5):791-798.
17	Martin RC 2nd, Durham AN, Besselink MG, et al. Irreversible electroporation in locally advanced pancreatic cancer: A　call for standardization of energy delivery[J]. J Surg Oncol, 2016,114(7):865-871.
18	Martin RC. Irreversible electroporation of locally advanced pancreatic headadenocarcinoma[J]. J Gastrointest Surg,2013,17(10):1850-1856.
19	Scheffer HJ, Vroomen LG, de Jong MC, et al. Ablation of locally advanced pancreatic cancer with percutaneous irreversible　electroporation: results of the Phase I/II PANFIRE study[J]. Radiology, 2017, 282(2):585-597.
20	Månsson C, Nilsson A, Karlson BM. Severe complications with irreversible electroporation of the pancreas in the presence of a metallic stent: a warning of a procedure that never should be performed[J]. Acta Radiol Short Rep, 2014,3(11):2047981614556409.
21	Månsson C, Brahmstaedt R, Nilsson A, et al. Percutaneous irreversible electroporation for treatment of locally advanced pancreatic cancer following chemotherapy or radiochemotherapy[J]. Eur J SurgOncol, 2016,42(9):1401-1406.
22	Yan L, Chen YL, Su M, et al. A single-institution experience with open irreversible electroporation for locally advanced pancreatic carcinoma[J]. Chin Med J (Engl), 2016 ,129(24):2920-2925.
23	Martin RC, Schwartz E, Adams J, et al. Intra–operative anesthesia management in patients undergoing surgical irreversible electroporation of the pancreas, liver, kidney, and retroperitoneal tumors[J].Anesth Pain Med, 2015, 5(3):e22786.
24	Nielsen K, Scheffer HJ, Vieveen JM, et al. Anaesthetic management during open andpercutaneous irreversible electroporation[J]. Br J Anaesth, 2014, 113(6):985-992.
25	Martin RC 2nd, Kwon D, Chalikonda S, et al. Treatment of 200 locally advanced (stage III) pancreaticadenocarcinoma patients with irreversible electroporation: safety and efficacy[J].Ann Surg, 2015, 262(3):486-494.
26	Narayanan G, Hosein PJ, Beulaygue IC, et al. Percutaneous image-guided irreversible electroporation for the treatment of unresectable, locally advanced pancreatic adenocarcinoma[J]. J VascInterv Radiol, 2017, 28(3):342-348.
27	Kluger MD, Epelboym I, Schrope BA, et al. Single-Institution experience with irreversible electroporation for T4 pancreatic cancer: first 50 patients[J]. Ann Surg Oncol, 2016, 23(5):1736-1743.
28	Belfiore G, Belfiore MP, Reginelli A, et al. Concurrent chemotherapy alone versus irreversible　electroporation followed by chemotherapy on survival in patients with locally　advanced pancreatic cancer[J]. Med Oncol, 2017, 34(3):38.
29	Martin RC 2nd, McFarland K, Ellis S, et al. Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma[J]. J Am Coll Surg, 2012, 215(3):361-369.
30	Martin RC 2nd, McFarland K, Ellis S, et al. Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival[J]. Ann Surg Oncol, 2013, 20(Suppl 3):S443-449.
31	Lambert L, Horejs J, Krska Z, et al. Treatment of locally advanced pancreatic cancer by percutaneous andintraoperative irreversible electroporation: general hospital cancer center experience[J]. Neoplasma, 2016,63(2):269-273.
32	Månsson C, Bergenfeldt M, Brahmstaedt R, et al. Safety and preliminary efficacy of ultrasound-guided percutaneous irreversible　electroporation for treatment of localized pancreatic cancer[J]. Anticancer Res,2014,34(1):289-293.
33	Belfiore MP, Ronza FM, Romano F, et al. Percutaneous CT-guided irreversible electroporation followed by chemotherapy as a novel neoadjuvant protocol in locally advancedpancreatic cancer: Our preliminary experience[J]. Int J Surg, 2015, 21(Suppl 1):S34-39.
34	Bond L, Schulz B, VanMeter T, et al. Intra-operative navigation of a 3-dimensional needle localization system for precision of irreversible electroporation needles in locally advanced pancreatic cancer[J]. Eur J Surg Oncol, 2017 ,43(2):337-343.
35	Akinwande O, Ahmad SS, Van Meter T, et al. CT findings of　patients treated with irreversible electroporation for locally advanced　pancreatic cancer[J]. J Oncol, 2015,2015:680319.
36	Vroomen LGPH, Scheffer HJ, Melenhorst MCAM, et al. MR and CT imaging characteristicsand ablation zone volumetry of locally advanced pancreatic cancer treated with　irreversible electroporation[J]. Eur Radiol, 2017 ,27(6):2521-2531.
37	Ekici Y, Tezcaner T, Aydın HO, et al. Arterial complication ofirreversible electroporation procedure for locally advanced pancreatic cancer[J].World J Gastrointest Oncol, 2016,8(10):751-756.
38	Philips P, Li Y, Li S, et al. Efficacy of irreversible electroporation in human pancreatic adenocarcinoma: advanced murine model[J]. Mol Ther Methods Clin Dev, 2015 ,2:15001.
39	Wimmer T, Srimathveeravalli G, Gutta N, et al. Comparison of simulation-based treatment planning with imaging and pathology outcomes for percutaneous CT-guided irreversible electroporation of the porcine pancreas: a pilot study[J]. J Vasc Interv Radiol, 2013,24(11):1709-1718.
40	Martin RC 2nd. Irreversible electroporation of locally advanced pancreatic neck/body adenocarcinoma[J]. J Gastrointest Oncol, 2015 ,6(3):329-335.
41	Scheffer HJ, Melenhorst MC, Vogel JA, et al. Percutaneous irreversible electroporation of locally advanced　pancreatic carcinoma using the dorsal approach: a case report[J]. Cardiovasc Intervent Radiol, 2015,38(3):760-765.
42	Dunki-Jacobs EM, Philips P, Martin RC 2nd. Evaluation of resistance as ameasure of successful tumor ablation during irreversible electroporation of thepancreas[J]. J Am Coll Surg, 2014, 218(2):179-187.
43	Bhutiani N, Agle S, Li Y, et al. Irreversible electroporation enhances delivery of gemcitabine to pancreatic adenocarcinoma[J]. J Surg Oncol, 2016,114(2):181-186.
44	Li J, Liu F, Gupta S, et al. Interventional nanotheranostics of pancreatic ductal adenocarcinoma[J]. Theranostics, 2016 ,6(9):1393-1402.
45	Li X, Xu K, Li W, et al. Immunologic response to tumorablation with irreversible electroporation[J]. PLoS One, 2012,7(11):e48749.
46	Goswami I, Coutermarsh-Ott S, Morrison RG, et al. Irreversible electroporation inhibits pro-cancer inflammatory signaling in triple negative breast cancer cells[J]. Bioelectrochemistry, 2017,113:42-50.
47	Lin M, Liang S, Wang X, et al. Short-termclinical efficacy of percutaneous irreversible electroporation combined with　allogeneic natural killer cell for treating metastatic pancreatic cancer[J]. Immunol Lett, 2017,186:20-27.
48	Martin RC 2nd, Agle S, Schlegel M, et al. Efficacy of preoperative immunonutrition in locally advanced pancreatic cancer　undergoing irreversible electroporation (IRE) [J]. Eur J Surg Oncol, 2017,43(4):772-779.

[1]	章建全, 程杰, 陈红琼, 闫磊. 采用ACR-TIRADS评估甲状腺消融区的调查研究[J/OL]. 中华医学超声杂志（电子版）, 2024, 21(10): 966-971.
[2]	常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[3]	杨建波, 马欢, 黄小梅, 刘华柱. 结肠镜辅助下EMR、CSP和RFA术治疗直径＜1cm结直肠息肉的疗效和安全性比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 76-79.
[4]	谢田伟, 庞于樊, 吴丽. 超声引导下不同消融术对甲状腺良性结节体积缩减率、复发率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 80-83.
[5]	李云龙, 夏旭良, 江志强, 刘伟, 刘凯, 唐立, 刘昊中, 张思远. 三种方法治疗分化型甲状腺癌的临床疗效[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 487-489.
[6]	林巧, 周丽. RFA联合LAH术治疗原发性肝癌并门静脉癌栓的临床效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 521-524.
[7]	李月平, 李科, 乔禹铭, 钟美浓. 前列腺热蒸汽消融术医护康一体化快速康复模式初探[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 464-472.
[8]	臧宇, 姚胜, 朱新勇, 戎世捧, 田智超. 低温等离子射频消融治疗腹壁疝术后补片感染的临床效果[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 687-692.
[9]	宋华传, 季鹏, 姚焕章, 王永帅, 张珅瑜, 宋瑞鹏, 王继洲. 腹腔镜肝切除术联合微波消融治疗多发性结直肠癌肝转移[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(04): 222-226.
[10]	张瑜, 姜梦妮. 基于DWI信号值构建局部进展期胰腺癌放化疗生存获益预测模型[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 657-664.
[11]	韦巧玲, 黄妍, 赵昌, 宋庆峰, 陈祖毅, 黄莹, 蒙嫦, 黄靖. 肝癌微波消融术后中重度疼痛风险预测列线图模型构建及验证[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 715-721.
[12]	楚海强, 杨远游, 任刚. 胰腺癌放射治疗联合其他治疗方法的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(04): 392-396.
[13]	钟小军, 杨清峰, 邹忠元, 丘宁宁, 李见英, 邹四珍, 黄小琴, 郭冠华, 牛立志. 支气管镜联合数字减影血管造影在恶性气道狭窄金属支架置入中的应用[J/OL]. 中华介入放射学电子杂志, 2024, 12(04): 317-322.
[14]	冯建宇, 郝珂楠, 陈小晶, 何晓峰, 赵玮. 集束化护理在腰椎间盘突出臭氧消融术治疗中的应用[J/OL]. 中华介入放射学电子杂志, 2024, 12(04): 397-400.
[15]	王楠钧, 马燕, 李隆松, 牛晓彤, 刘圣圳, 毕雅维, 苏松, 柴宁莉, 令狐恩强. 不同年龄段胃低级别上皮内瘤变患者内镜下射频消融术的疗效对比分析[J/OL]. 中华胃肠内镜电子杂志, 2024, 11(04): 238-242.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Irreversible electroporation ablation for the treatment of pancreatic cancer: present and prospects

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Irreversible electroporation ablation for the treatment of pancreatic cancer: present and prospects